Details for New Drug Application (NDA): 218289
✉ Email this page to a colleague
The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
Summary for 218289
Tradename: | BETAMETHASONE DIPROPIONATE |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | betamethasone dipropionate |
Patents: | 0 |
Pharmacology for NDA: 218289
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 218289
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | OINTMENT, AUGMENTED;TOPICAL | 218289 | ANDA | Aurobindo Pharma Limited | 59651-699 | 59651-699-14 | 1 TUBE in 1 CARTON (59651-699-14) / 15 g in 1 TUBE |
BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | OINTMENT, AUGMENTED;TOPICAL | 218289 | ANDA | Aurobindo Pharma Limited | 59651-699 | 59651-699-46 | 1 TUBE in 1 CARTON (59651-699-46) / 45 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT, AUGMENTED;TOPICAL | Strength | EQ 0.05% BASE | ||||
Approval Date: | Apr 10, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription